| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.001 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.002 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.00042 | 1 |